ICU Medical Inc has a consensus price target of $119.4, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from Raymond James, Keybanc, and Keybanc on June 17, 2024, February 28, 2024, and February 6, 2024. With an average price target of $135 between Raymond James, Keybanc, and Keybanc, there's an implied 14.43% upside for ICU Medical Inc from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/21/2024 | Buy Now | — | Needham | Mike Matson | — | Initiates | → Hold | Get Alert |
06/17/2024 | Buy Now | 14.43% | Raymond James | Jayson Bedford | → $135 | Upgrade | Market Perform → Outperform | Get Alert |
02/28/2024 | Buy Now | 15.27% | Keybanc | Brett Fishbin | $134 → $136 | Maintains | Overweight | Get Alert |
02/06/2024 | Buy Now | 13.58% | Keybanc | Brett Fishbin | → $134 | Initiates | → Overweight | Get Alert |
12/14/2023 | Buy Now | -6.76% | CL King | Kristen Stewart | → $110 | Initiates | → Buy | Get Alert |
05/09/2023 | Buy Now | 83.08% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
11/08/2022 | Buy Now | — | Raymond James | Jayson Bedford | — | Downgrade | Outperform → Market Perform | Get Alert |
08/09/2022 | Buy Now | 61.04% | Raymond James | Jayson Bedford | $208 → $190 | Maintains | Outperform | Get Alert |
08/09/2022 | Buy Now | 90.71% | Keybanc | Matthew Mishan | $230 → $225 | Maintains | Overweight | Get Alert |
08/08/2022 | Buy Now | 76.3% | Raymond James | Jayson Bedford | $235 → $208 | Maintains | Outperform | Get Alert |
08/03/2022 | Buy Now | 94.95% | Keybanc | Matthew Mishan | $265 → $230 | Maintains | Overweight | Get Alert |
05/10/2022 | Buy Now | 124.61% | Keybanc | Matthew Mishan | $280 → $265 | Maintains | Overweight | Get Alert |
05/10/2022 | Buy Now | 99.19% | Raymond James | Jayson Bedford | $265 → $235 | Maintains | Outperform | Get Alert |
02/28/2022 | Buy Now | 124.61% | Raymond James | Jayson Bedford | $286 → $265 | Maintains | Outperform | Get Alert |
10/22/2021 | Buy Now | 137.33% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
09/09/2021 | Buy Now | 142.41% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
09/09/2021 | Buy Now | 155.98% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
08/06/2021 | Buy Now | 90.71% | Keybanc | Matthew Mishan | — | Maintains | Overweight | Get Alert |
08/05/2021 | Buy Now | 86.47% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
The latest price target for ICU Medical (NASDAQ:ICUI) was reported by Needham on June 21, 2024. The analyst firm set a price target for $0.00 expecting ICUI to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for ICU Medical (NASDAQ:ICUI) was provided by Needham, and ICU Medical initiated their hold rating.
The last upgrade for ICU Medical Inc happened on June 17, 2024 when Raymond James raised their price target to $135. Raymond James previously had a market perform for ICU Medical Inc.
The last downgrade for ICU Medical Inc happened on November 8, 2022 when Raymond James changed their price target from N/A to N/A for ICU Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ICU Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ICU Medical was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
While ratings are subjective and will change, the latest ICU Medical (ICUI) rating was a initiated with a price target of $0.00 to $0.00. The current price ICU Medical (ICUI) is trading at is $117.98, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.